A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to see if it is safe to give L-743,872 to men with candidal esophagitis, an AIDS-related yeast infection in the esophagus.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Caspofungin

Criteria

Inclusion Criteria

You may be eligible for this study if you:

• Are an 18- to 65-year-old man with candidal esophagitis.